16:05 EDT Longeveron (LGVN) files to sell 3.85M shares of Class A common stock
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGVN:
- Longeveron licenses patent for stem cell technology from University of Miami
- Longeveron Gains FDA Approval for Laromestrocel Trial
- Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
- Longeveron announces FDA approval of IND application for laromestrocel study
- Longeveron appoints Powell as Chief Business Officer